RxDoctor Payments Data

Jennifer Hasty, APRN

Nurse Practitioner · Magnolia, MSNPI 1497426548

Payments from drug & device makers

$231in general payments, 2019–2025

Across 11 payments — averaging $21.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$68
  • AstraZeneca$67
  • AbbVie$23
  • Renalytix AI, Inc.$23
  • Teva Pharmaceuticals USA, Inc.$19
  • Bayer$17
  • plus $14 from 1 others

What the payments were for

  • Food & beverage$231100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$231 in reported general payments places this provider in the 50th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$93,688
Medicare patients
401
Services billed
1,281

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban44$28,025
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$19,229
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$14,990
TrulicityDulaglutide11$11,163
LinzessLinaclotide19$10,468
FarxigaDapagliflozin Propanediol12$7,311
MyrbetriqMirabegron11$4,845
Atorvastatin Calcium119$1,278
Memantine Hcl18$1,224
Levothyroxine Sodium46$1,181
Gabapentin61$1,088
Trazodone Hcl37$617
Carbamazepine ErCarbamazepine24$611
Bumetanide16$568
ClopidogrelClopidogrel Bisulfate34$540

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere, Farxiga$67$22,30126 claims
AbbVieLinzess$23$10,46819 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Magnolia

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →